Why Peter Marks Was Asked To Leave the FDA
Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for ...
Dr. Peter Marks, top vaccine official at FDA, resigns and criticizes RFK Jr.
Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from ...
Peter Marks, top FDA vaccine official, forced to resign
Dr. Peter Marks, the top vaccine regulator at the U.S. Food and Drug Administration, was forced to resign, citing Health and ...
Top vaccine official Peter Marks forced out at FDA, WSJ reports
The U.S. Food and Drug Administration's top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal ...
FDA's top vaccine scientist, Dr. Peter Marks, is out
In his resignation letter, Marks wrote that health secretary Robert F. Kennedy Jr. wanted "subservient confirmation of his ...
"Misinformation and lies": Peter Marks resigns from FDA, slams RFK
In the end, it wasn't possible to work with Robert F. Kennedy Jr. 's views on vaccinations, the FDA's top vaccine official ...
Who Is Dr. Peter Marks? FDA’s Top Vaccine Official Quits, Citing RFK Jr.’s ‘Misinformation And Lies.’
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific ...
The Peter Marks effect
The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine ...
Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
The Food and Drug Administration’s top vaccine regulator Peter Marks has resigned, citing Sec. Kennedy Robert F. Kennedy ...
Fierce Pharma2d
For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Fierce Pharma4d
As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
How Peter Marks' FDA departure is impacting pharma, biotech stocks
The abrupt resignation announcement that came late on Friday, March 28, from Peter Marks, who heads the U.S. FDA's Center for ...